UroGen Pharma Ltd. (URGN)
36.61
+0.03
(+0.08%)
USD |
NASDAQ |
Oct 15, 16:00
36.57
-0.04
(-0.11%)
After-Hours: 20:00
UroGen Pharma Cash from Operations (TTM) : -170.43M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -170.43M |
| March 31, 2026 | -175.58M |
| December 31, 2025 | -172.29M |
| September 30, 2025 | -143.64M |
| June 30, 2025 | -123.90M |
| March 31, 2025 | -107.04M |
| December 31, 2024 | -96.76M |
| September 30, 2024 | -94.88M |
| June 30, 2024 | -83.38M |
| March 31, 2024 | -79.63M |
| December 31, 2023 | -73.70M |
| September 30, 2023 | -82.21M |
| June 30, 2023 | -82.56M |
| March 31, 2023 | -86.11M |
| December 31, 2022 | -84.30M |
| September 30, 2022 | -85.50M |
| June 30, 2022 | -87.62M |
| Date | Value |
|---|---|
| March 31, 2022 | -83.53M |
| December 31, 2021 | -86.94M |
| September 30, 2021 | -88.45M |
| June 30, 2021 | -96.24M |
| March 31, 2021 | -101.04M |
| December 31, 2020 | -109.28M |
| September 30, 2020 | -112.51M |
| June 30, 2020 | -99.19M |
| March 31, 2020 | -90.14M |
| December 31, 2019 | -72.44M |
| September 30, 2019 | -55.78M |
| June 30, 2019 | -51.46M |
| March 31, 2019 | -44.55M |
| December 31, 2018 | -36.24M |
| September 30, 2018 | -32.66M |
| June 30, 2018 | -20.97M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Xencor, Inc. | -205.81M |
| MeiraGTx Holdings Plc | 13.69M |
| Insmed, Inc. | -778.92M |
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Viking Therapeutics, Inc. | -418.44M |